Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ludwig researchers extend potential for personalized immunotherapy to ovarian cancer, other tumors

A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.

15 Mar 2018

Researchers identify novel gene involved in familial breast cancer

An international research consortium led by Dr Jordi Surrallés, director of the Genetics Service at the Hospital de Sant Pau and professor of Genetics at the UAB, and by Dr Miquel Àngel Pujana, director of the ProCURE Research Programme of the Catalan Institute of Oncology, has identified a novel gene involved in this type of cancer, known as EDC4.

14 Mar 2018

New sample storage technique could lead to better health care in resource-limited regions

Blood and urine tests play vital roles in modern medicine. Yet in vast regions of the world where refrigeration is not available, preserving samples for testing is virtually impossible.

28 Feb 2018

Persistent bloating can be a sign of ovarian cancer, warns charity

The charity Target Ovarian Cancer that there is an "alarmingly low rate of awareness" among women that persistent bloating is a major symptom of ovarian cancer.

20 Feb 2018

Research identifies gene variants that play key role in how ovarian cancer patients process chemotherapy

Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

16 Feb 2018

Fathers maybe passing on ovarian cancer genes to their daughters

According to a team of researchers from the Roswell Park Cancer Institute, a new gene mutation could be responsible for ovarian cancers and this could be passed on from fathers to their daughters.

16 Feb 2018

Using Smartphones for Cancer Diagnosis and Management

Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a “less is more” approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro’s research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.

From Pittcon 14 Feb 2018

USPSTF recommends against ovarian cancer screening in women without symptoms

The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in women without symptoms and who are not known to be at high risk (such as those who have certain hereditary cancer syndromes that increase the risk for ovarian cancer).

13 Feb 2018

Patients with Huntington's have lesser cancer than general population

Patients with Huntington's disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.

12 Feb 2018

Scientists develop new array to identify biomarkers for wide range of diseases

Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.

12 Feb 2018

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

While cancer treatment advances are being made in the areas of precision medicine and immunotherapy, a unique combination of traditional therapies can also provide some cancer patients a treatment option that may provide significant benefit.

11 Feb 2018

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Selected by the American Society of Clinical Oncology to first outing during its Genitourinary Cancers Symposium, Translating Evidence to Multidisciplinary Care, February 8 - 10 (San Francisco, USA), Joaquin Mateo, Principal Investigator of VHIO's recently created Prostate Cancer Translational Research Group, will today reveal findings from a retrospective and international study showing for the first time that patients with inherited DNA repair mutations benefit from standard therapies in a similar way to other metastatic prostate cancer patients.

9 Feb 2018

Researchers use innovative method to screen kinases for cancer drug's effectiveness

In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.

5 Feb 2018

Researchers identify promising new drug target for Ewing sarcoma

Screening a class of recently-developed drug compounds -- so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins -- against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.

25 Jan 2018

New test predicts which BRCA2 gene mutations lead to breast, ovarian cancers

A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.

25 Jan 2018

Researchers develop single blood test that screens for 8 cancer types

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

19 Jan 2018

Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations

A new study published yesterday in the Journal of the National Cancer Institute suggests that, in comparison with just screening women who are at high risk of carrying breast and ovarian cancer gene mutations, screening the entire population for these mutations will be more cost-effective.

18 Jan 2018

Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations

Screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current clinical approach, according to research published today in the Journal of the National Cancer Institute.

18 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Ludwig researchers extend potential for personalized immunotherapy to ovarian cancer, other tumors

Researchers identify novel gene involved in familial breast cancer

New sample storage technique could lead to better health care in resource-limited regions

Persistent bloating can be a sign of ovarian cancer, warns charity

Research identifies gene variants that play key role in how ovarian cancer patients process chemotherapy

Fathers maybe passing on ovarian cancer genes to their daughters

Using Smartphones for Cancer Diagnosis and Management

USPSTF recommends against ovarian cancer screening in women without symptoms

Patients with Huntington's have lesser cancer than general population

Scientists develop new array to identify biomarkers for wide range of diseases

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Researchers identify promising new drug target for Ewing sarcoma

New test predicts which BRCA2 gene mutations lead to breast, ovarian cancers

Researchers develop single blood test that screens for 8 cancer types

Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations

Research reveals cost-effectiveness of whole-population screening for breast, ovarian cancer gene mutations

FDA grants approval for first drug to treat inherited breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in